Cyclophosphamide
- Product NDC
- 10019-984
- 11-digit product format
- 100190984
- Labeler code
- 10019
- Product ID
- 10019-984_dc40762e-5ccf-402c-a7b1-4c9dee737811
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclophosphamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Baxter Healthcare Corporation
- Application
- NDA012141
- Marketing category
- NDA
- Marketing start
- 2020-08-07
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 50 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclophosphamide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOPHOSPHAMIDE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8N3DW7272P |
| Rxcui | 197549, 197550 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10019-984-01 | Cyclophosphamide | 1 in 1 CARTON | TABLET | 1 | | 7 |
| 10019-984-09 | Cyclophosphamide | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10019-984 | CYCLOPHOSPHAMIDE TABLET [BAXTER HEALTHCARE COMPANY] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250417_769ded74-6186-40a8-8e44-ceff67287451.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10019-984-01 | 10019098401 | 1 BOTTLE in 1 CARTON (10019-984-01) / 100 TABLET in 1 BOTTLE (10019-984-09) | 1 bottle | 2020-08-07 | 0000-00-00 | No | No | Current |
| 10019-984-09 | 10019098409 | 100 in 1 BOTTLE | | | | | | Historical |